60 Degrees Pharmaceuticals
SXTP
6 hedge funds and large institutions have $41.4K invested in 60 Degrees Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.
0.08% more ownership
Funds ownership: 0.01% → 0.09% (+0.08%)
33% less funds holding
Funds holding: 9 → 6 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
54% less capital invested
Capital invested by funds: $90.1K → $41.4K (-$48.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$18.7K |
| 2 |
VF
Virtu Financial
New York
|
+$16.5K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$7.39K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.63K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$813 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CBT
Central Bank & Trust
Lexington,
Kentucky
|
-$41.8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$9.61K |
| 3 |
HF
HRT Financial
New York
|
-$7K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$4.35K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.36K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $16K | +$16.5K | +446 | +237% |
|
|
2
Citadel Advisors
Miami,
Florida
| $12.7K | +$18.7K | +505 | New |
|
|
3
National Bank of Canada
Montreal,
Quebec, Canada
| $5K | +$7.39K | +200 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $4.14K | +$813 | +22 | +15% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1.84K | +$1.63K | +44 | +147% |
|
|
SHF
6
Safe Harbor Fiduciary
Pensacola,
Florida
| $1.72K | +$2.55K | +69 | New |
|
7
Bank of America
Charlotte,
North Carolina
| $8 | – | – | – |
|
|
CBT
8
Central Bank & Trust
Lexington,
Kentucky
| – | -$41.8K | -696 | Closed |
|
|
9
Geode Capital Management
Boston,
Massachusetts
| – | -$9.61K | -158 | Closed |
|
|
HF
10
HRT Financial
New York
| – | -$7K | -120 | Closed |
|
|
TSS
11
Two Sigma Securities
New York
| – | -$4.35K | -72 | Closed |
|
|
12
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$3.36K | -55 | Closed |
|
|
RJA
13
Raymond James & Associates
St Petersburg,
Florida
| – | -$2.53K | -42 | Closed |
|
SXTP Hedge Fund Activity: Q3 2024 in Review
6 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q3 2024, worth a combined $41.4K — down 54% from $90.1K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SXTP and 3 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $18.7K. The largest seller was Central Bank & Trust, exiting entirely with an estimated $41.8K sold.
- 6 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q3 2024, down from 9 in Q2 2024.
- Funds reported $41.4K of 60 Degrees Pharmaceuticals stock for Q3 2024, down 54% quarter-over-quarter.
- 3 funds opened new 60 Degrees Pharmaceuticals positions in Q3 2024 and 6 closed out, a net change of -3 holders.
- The largest 60 Degrees Pharmaceuticals buyer in Q3 2024 was Citadel Advisors, an estimated $18.7K added.
- The largest 60 Degrees Pharmaceuticals seller in Q3 2024 was Central Bank & Trust, an estimated $41.8K sold.
Based on aggregated 13F filings for Q3 2024.